⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2092 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL10400041 | 0.67 | — | — | |
| Fluoride SCHEMBL3369470 | 0.67 | — | — | |
| SCHEMBL5470 | 0.63 | — | — | |
| SCHEMBL9524745 | 0.62 | — | — | |
| Carbon Dioxide SCHEMBL2359185 | 0.58 | — | — | |
| SCHEMBL9956019 | 0.58 | — | — | |
| SCHEMBL1054228 | 0.58 | — | — | |
| SCHEMBL5147784 | 0.54 | — | — | |
| SCHEMBL5820531 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220241369-A1 | COMPOSITIONS AND METHODS OF MODULATING INFLAMMATION | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2022-08-04 | — | — | US | disclosed |
| US-11331388-B1 | PTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosis | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2022-05-17 | — | — | US | disclosed |
| US-20200369750-A1 | HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY | 2020-11-26 | — | — | US | disclosed |
| EP-2992086-B1 | MODULATION OF REGULATORY T CELL FUNCTION VIA PROTEIN KINASE C-ETA | LA JOLLA INST ALLERGY & IMMUNOLOGY (US) | 2020-09-30 | — | — | EP | disclosed |
| WO-2020102108-A1 | COMPOSITIONS AND METHODS OF MODULATING INFLAMMATION | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2020-05-22 | — | — | WO | disclosed |
| US-10406218-B2 | Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of Mycobacterium tuberculosis | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2019-09-10 | — | — | US | disclosed |
| US-10370438-B2 | Histamine-releasing factor (HRF), HRF-receptor and methods of modulating inflammation | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180335433-A1 | COMPOSITIONS TARGETING PKC-THETA AND USES AND METHODS OF TREATING PKC-THETA PATHOLOGIES, ADVERSE IMMUNE RESPONSES AND DISEASES | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2018-11-22 | — | — | US | disclosed |
| US-20180111991-A1 | MODULATORS OF ACTIVIN AND METHODS FOR MODULATING IMMUNE RESPONSES AND T FOLLICULAR HELPER CELLS | LA JOLLA INST ALLERGY & IMMUNOLOGY (US) | 2018-04-26 | — | — | US | disclosed |
| WO-2017095428-A1 | MODULATORS OF ACTIVIN AND METHODS FOR MODULATING IMMUNE RESPONSES AND T FOLLICULAR HELPER CELLS | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2017-06-08 | — | — | WO | disclosed |
| US-20130084293-A1 | HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2013-04-04 | — | — | US | disclosed |
| WO-2012177788-A1 | MODULATORS OF 4-1BB AND IMMUNE RESPONSES | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2012-12-27 | — | — | WO | disclosed |
| WO-2012174412-A2 | COMPOSITIONS TARGETING PKC-THETA AND USES AND METHODS OF TREATING PKC-THETA PATHOLOGIES, ADVERSE IMMUNE RESPONSES AND DISEASES | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2012-12-20 | — | — | WO | disclosed |
| WO-2011123697-A2 | HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2011-10-06 | — | — | WO | disclosed |
| WO-2011057144-A2 | METHODS FOR MODULATING LIF ACTIVITY, TREATING IMMUNE DISORDERS AND DISEASES, AND STIMULATINGS IMMUNE RESPONSES | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2011-05-12 | — | — | WO | disclosed |
| US-6815575-B1 | FOR IDENTIFYING GENES THAT PREVENT CELL/TISSUE (NEURAL, MUSCLE, MESODERM, KIDNEY) DEGRADATION/APOPTOSIS USING TRANSGENIC DROSOPHILA | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2004-11-09 | — | — | US | disclosed |
| US-20030204859-A1 | Animal model of polyglutamine toxicity, methods of use, and modulators of polyglutamine toxicity | CALIFORNIA INSTITUTE OF TECHNOLOGY, A CALIFORNIA CORPORATION | 2003-10-30 | — | — | US | disclosed |
| WO-2003080662-A1 | PROTEIN KINASE C MODULATORS, THEIR AMINOACID AND NUCLEOTIDE SEQUENCES AND USES THEREOF | GANDINI ENRICO (IT) | 2003-10-02 | — | — | WO | disclosed |
| WO-2001012238-A1 | AN ANIMAL MODEL OF POLYGLUTAMINE TOXICITY, METHODS OF USE, AND MODULATORS OF POLYGLUTAMINE TOXICITY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2001-02-22 | — | — | WO | disclosed |
| WO-2000036083-A2 | PKC-INTERACTING COUSIN OF TRX (PICOT) POLYPEPTIDES, POLYNUCLEOTIDES, AND METHODS OF MAKING AND USING THEM | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 2000-06-22 | — | — | WO | disclosed |